NMTC Earnings & Financial Statements
NeuroOne Medical Technologies Corporation
$1.05
-$0.01(-0.97%)
31
Overall
40
Value
10
Tech
44
Quality
Market Cap
$9.65M
Volume
166.19K
52W Range
$0.96 - $6.12
Target Price
$7.27
NMTC earnings and financial statements: NeuroOne Medical Technologies Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
NMTC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $9.10M | $3.45M | $1.95M | $171.2K | $178.1K |
| Cost of revenue | $3.96M | $2.37M | $1.50M | $242.0K | $275.9K |
| Operating income | -$4.23M | -$11.89M | -$11.96M | -$10.03M | -$10.22M |
| EBITDA | -$2.82M | -$11.97M | -$11.66M | -$9.91M | -$9.86M |
| Net income | -$3.61M | -$12.32M | -$11.86M | -$10.00M | -$9.95M |
| EPS (diluted) | $-0.09 | $-2.76 | $-3.90 | $-3.78 | $-5.58 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $10.79M | $5.37M | $8.10M | $12.82M | $7.94M |
| Total liabilities | $3.71M | $4.55M | $1.85M | $3.22M | $1.38M |
| Shareholders’ equity | $7.07M | $822.0K | $6.25M | $9.60M | $6.55M |
| Cash and equivalents | $6.60M | $1.46M | $5.32M | $8.16M | $6.90M |
| Long-term debt | $143.1K | $194.4K | $55.3K | $119.6K | $202.9K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$2.84M | -$11.01M | -$12.89M | -$7.52M | -$8.60M |
| Capital expenditure | -$81.7K | -$120.2K | -$376.6K | -$275.2K | -$67.1K |
| Free cash flow | -$2.92M | -$11.13M | -$13.26M | -$7.79M | -$8.67M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMTC | $1.05 | -1.0% | 166.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NeuroOne Medical Technologies Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW